Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Have Never Been This Bullish On SurModics, Inc. (SRDX)

Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the big brokerage houses don’t follow. Small caps are where they can generate significant outperformance. That’s why we pay special attention to hedge fund activity in these stocks.

Is SurModics, Inc. (NASDAQ:SRDX) undervalued? Money managers are in an optimistic mood. The number of bullish hedge fund bets inched up by 4 recently. Our calculations also showed that SRDX isn’t among the 30 most popular stocks among hedge funds. SRDX was in 17 hedge funds’ portfolios at the end of December. There were 13 hedge funds in our database with SRDX holdings at the end of the previous quarter.

Why do we pay any attention at all to hedge fund sentiment? Our research has shown that hedge funds’ large-cap stock picks indeed failed to beat the market between 1999 and 2016. However, we were able to identify in advance a select group of hedge fund holdings that outperformed the market by 32 percentage points since May 2014 through March 12, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that’ll significantly underperform the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 27.5% through March 12, 2019. That’s why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

Matthew Hulsizer PEAK6 Capital

Let’s view the fresh hedge fund action encompassing SurModics, Inc. (NASDAQ:SRDX).

What does the smart money think about SurModics, Inc. (NASDAQ:SRDX)?

Heading into the first quarter of 2019, a total of 17 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 31% from one quarter earlier. By comparison, 12 hedge funds held shares or bullish call options in SRDX a year ago. So, let’s review which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

SRDX_may2019

Among these funds, Renaissance Technologies held the most valuable stake in SurModics, Inc. (NASDAQ:SRDX), which was worth $52.1 million at the end of the fourth quarter. On the second spot was Trigran Investments which amassed $37.6 million worth of shares. Moreover, Royce & Associates, AQR Capital Management, and Millennium Management were also bullish on SurModics, Inc. (NASDAQ:SRDX), allocating a large percentage of their portfolios to this stock.

As one would reasonably expect, key hedge funds have jumped into SurModics, Inc. (NASDAQ:SRDX) headfirst. Marshall Wace LLP, managed by Paul Marshall and Ian Wace, established the largest position in SurModics, Inc. (NASDAQ:SRDX). Marshall Wace LLP had $2.7 million invested in the company at the end of the quarter. Matthew Hulsizer’s PEAK6 Capital Management also made a $0 million investment in the stock during the quarter. The only other fund with a new position in the stock is Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as SurModics, Inc. (NASDAQ:SRDX) but similarly valued. These stocks are AC Immune SA (NASDAQ:ACIU), GoPro Inc (NASDAQ:GPRO), Funko, Inc. (NASDAQ:FNKO), and Nova Measuring Instruments Ltd. (NASDAQ:NVMI). This group of stocks’ market values resemble SRDX’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
ACIU 8 71314 -1
GPRO 13 47714 -1
FNKO 13 39529 3
NVMI 9 74480 0
Average 10.75 58259 0.25

View table here if you experience formatting issues.

As you can see these stocks had an average of 10.75 hedge funds with bullish positions and the average amount invested in these stocks was $58 million. That figure was $144 million in SRDX’s case. GoPro Inc (NASDAQ:GPRO) is the most popular stock in this table. On the other hand AC Immune SA (NASDAQ:ACIU) is the least popular one with only 8 bullish hedge fund positions. Compared to these stocks SurModics, Inc. (NASDAQ:SRDX) is more popular among hedge funds. Our calculations showed that top 15 most popular stocks) among hedge funds returned 24.2% through April 22nd and outperformed the S&P 500 ETF (SPY) by more than 7 percentage points. Unfortunately SRDX wasn’t nearly as popular as these 15 stock and hedge funds that were betting on SRDX were disappointed as the stock returned -10.7% and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 15 most popular stocks) among hedge funds as 13 of these stocks already outperformed the market this year.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...